Jiangsu Aidea Pharmaceutical Co Ltd (688488) - Total Liabilities

Latest as of September 2025: CN¥762.97 Million CNY ≈ $111.65 Million USD

Based on the latest financial reports, Jiangsu Aidea Pharmaceutical Co Ltd (688488) has total liabilities worth CN¥762.97 Million CNY (≈ $111.65 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Jiangsu Aidea Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Jiangsu Aidea Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Jiangsu Aidea Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.

Jiangsu Aidea Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangsu Aidea Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Gilat Satellite Networks Ltd TA:GILT	Israel	ILA220.97 Million
Cementos Pacasmayo S.A.A F:EPCC	Germany	€1.86 Billion
Tyntek Corp TW:2426	Taiwan	NT$972.75 Million
Xingye Leather Technology Co Ltd SHE:002674	China	CN¥1.93 Billion
Carlyle Secured Lending Inc NASDAQ:CGBD	USA	$1.62 Billion
Allied Circuit Co Ltd TWO:8155	Taiwan	NT$2.74 Billion
VBG Group AB (publ) ST:VBG-B	Sweden	Skr3.30 Billion
Mid Penn Bancorp NASDAQ:MPB	USA	$5.32 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Jiangsu Aidea Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688488 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.78	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu Aidea Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual total liabilities of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥802.48 Million ≈ $117.43 Million	+29.22%
2023-12-31	CN¥621.03 Million ≈ $90.88 Million	+36.12%
2022-12-31	CN¥456.23 Million ≈ $66.76 Million	+265.52%
2021-12-31	CN¥124.82 Million ≈ $18.26 Million	+43.52%
2020-12-31	CN¥86.97 Million ≈ $12.73 Million	-61.30%
2019-12-31	CN¥224.74 Million ≈ $32.89 Million	+20.68%
2018-12-31	CN¥186.24 Million ≈ $27.25 Million	+28.31%
2017-12-31	CN¥145.14 Million ≈ $21.24 Million	+1.39%
2016-12-31	CN¥143.16 Million ≈ $20.95 Million	--

About Jiangsu Aidea Pharmaceutical Co Ltd

SHG:688488 China Biotechnology

Market Cap

$773.98 Million

CN¥5.29 Billion CNY

Market Cap Rank

#10209 Global

#2757 in China

Share Price

CN¥12.57

Change (1 day)

-0.32%

52-Week Range

CN¥12.50 - CN¥22.16

All Time High

CN¥42.39